171 related articles for article (PubMed ID: 36525320)
41. Primary diffuse large B-cell lymphoma in the maxilla: A case report.
Zou H; Yang H; Zou Y; Lei L; Song L
Medicine (Baltimore); 2018 May; 97(20):e10707. PubMed ID: 29768336
[TBL] [Abstract][Full Text] [Related]
42. Primary breast lymphoma - a case report.
Rajabto W; Angkasa YK; Harahap AS; Ham MF; Brahma B
Klin Onkol; 2021; 34(6):477-480. PubMed ID: 34911334
[TBL] [Abstract][Full Text] [Related]
43. Role of virological serum markers in patients with both hepatitis B virus infection and diffuse large B-cell lymphoma.
Zhou X; Wuchter P; Egerer G; Kriegsmann M; Mataityte A; Koelsche C; Witzens-Harig M; Kriegsmann K
Eur J Haematol; 2019 Oct; 103(4):410-416. PubMed ID: 31338887
[TBL] [Abstract][Full Text] [Related]
44. Chidamide combined with ibrutinib improved the prognosis of primary bone marrow diffuse large B cell lymphoma.
Tian C; Chen Z; Li Y
J Int Med Res; 2020 Jul; 48(7):300060520936053. PubMed ID: 32643971
[TBL] [Abstract][Full Text] [Related]
45. Widespread primary cutaneous diffuse large B-cell lymphoma, leg type, with nasal involvement.
Bostan E; Akdogan N; Saglam Ayhan A; Ersoy Evans S
Int Wound J; 2019 Aug; 16(4):1063-1067. PubMed ID: 31099459
[No Abstract] [Full Text] [Related]
46. [Primary diffuse large B-cell lymphoma of the uterine cervix successfully treated with rituximabplus cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy-a case report].
Hashimoto A; Fujimi A; Kanisawa Y; Matsuno T; Okuda T; Minami S; Doi T; Ishikawa K; Uemura N; Jyomen Y; Tomaru U
Gan To Kagaku Ryoho; 2013 Dec; 40(13):2589-92. PubMed ID: 24335377
[TBL] [Abstract][Full Text] [Related]
47. Improvement of survival in patients with primary cutaneous diffuse large B-cell lymphoma, leg type, in France.
Grange F; Joly P; Barbe C; Bagot M; Dalle S; Ingen-Housz-Oro S; Maubec E; D'Incan M; Ram-Wolff C; Dalac S; Templier I; Esteve E; Quereux G; Machet L; Leduc M; Dereure O; Laroche L; Saiag P; Vergier B; Beylot-Barry M
JAMA Dermatol; 2014 May; 150(5):535-41. PubMed ID: 24647650
[TBL] [Abstract][Full Text] [Related]
48. Cutaneous diffuse large B-cell lymphoma of the leg associated with chronic lymphedema.
González-Vela MC; González-López MA; Val-Bernal JF; Fernández-Llaca H
Int J Dermatol; 2008 Feb; 47(2):174-7. PubMed ID: 18211492
[TBL] [Abstract][Full Text] [Related]
49. Cutaneous B-cell lymphomas: 2015 update on diagnosis, risk-stratification, and management.
Wilcox RA
Am J Hematol; 2015 Jan; 90(1):73-6. PubMed ID: 25535037
[TBL] [Abstract][Full Text] [Related]
50. A case report of primary prostate intravascular large B cell lymphoma presenting as prostatic hyperplasia.
Zhu F; Pan H; Xiao Y; Li Q; Liu T; Liu X; Wu G; Li J; Zhang L
Medicine (Baltimore); 2019 Dec; 98(50):e18384. PubMed ID: 31852153
[TBL] [Abstract][Full Text] [Related]
51. [Rupture of hepatic lesion of diffuse large B-cell lymphoma following immunochemotherapy].
Segawa R; Natazuka T
Rinsho Ketsueki; 2022; 63(3):211-216. PubMed ID: 35387935
[TBL] [Abstract][Full Text] [Related]
52. 3A Comparison between R-THP-COP and R-CHOP Regimens for the Treatment of Diffuse Large B-cell Lymphoma in Old Patients: A Single-institution Analysis.
Araie H; Sakamaki I; Matsuda Y; Tai K; Ikegaya S; Itoh K; Kishi S; Oiwa K; Okura M; Tasaki T; Hosono N; Ueda T; Yamauchi T
Intern Med; 2017 Sep; 56(18):2407-2413. PubMed ID: 28824057
[TBL] [Abstract][Full Text] [Related]
53. Clinical features and treatment outcomes of primary cutaneous B-cell lymphoma: a single-center analysis in South Korea.
Kim MJ; Hong ME; Maeng CH; Jung HA; Hong JY; Choi MK; Kim SJ; Ko YH; Kim WS
Int J Hematol; 2015 Mar; 101(3):273-8. PubMed ID: 25552248
[TBL] [Abstract][Full Text] [Related]
54. Dose-adjusted EPOCH-R (etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab) in untreated aggressive diffuse large B-cell lymphoma with MYC rearrangement: a prospective, multicentre, single-arm phase 2 study.
Dunleavy K; Fanale MA; Abramson JS; Noy A; Caimi PF; Pittaluga S; Parekh S; Lacasce A; Hayslip JW; Jagadeesh D; Nagpal S; Lechowicz MJ; Gaur R; Lucas A; Melani C; Roschewski M; Steinberg SM; Jaffe ES; Kahl B; Friedberg JW; Little RF; Bartlett NL; Wilson WH
Lancet Haematol; 2018 Dec; 5(12):e609-e617. PubMed ID: 30501868
[TBL] [Abstract][Full Text] [Related]
55. Primary bone marrow diffuse large B cell lymphoma: a case series and review.
Chang H; Hung YS; Lin TL; Wang PN; Kuo MC; Tang TC; Wu JH; Dunn P; Shih LY
Ann Hematol; 2011 Jul; 90(7):791-6. PubMed ID: 21181164
[TBL] [Abstract][Full Text] [Related]
56. Molecular Mechanisms of Disease Progression in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type during Ibrutinib Therapy.
Fox LC; Yannakou CK; Ryland G; Lade S; Dickinson M; Campbell BA; Prince HM
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29899297
[TBL] [Abstract][Full Text] [Related]
57. [Clinicopathological features of primary cardiac CD5-positive and bcl-2 and C-MYC double expression diffuse large B-cell lymphoma].
Zhang F; Luo DL; Chen Y; Liu J; Luo LQ; He J; Yan JH; Xu J; Luo XL; Liu YH
Zhonghua Bing Li Xue Za Zhi; 2019 Dec; 48(12):951-954. PubMed ID: 31818069
[No Abstract] [Full Text] [Related]
58. Primary cutaneous diffuse large B cell lymphoma, leg type.
Dongre A; Kar S; Gondse S; Gangane N; Mehra BK
Indian J Dermatol Venereol Leprol; 2011; 77(2):212-4. PubMed ID: 21393962
[No Abstract] [Full Text] [Related]
59. Bone regeneration after chemotherapy for vault lymphoma.
Akamatsu Y; Kanamori M; Uenohara H; Tominaga T
BMJ Case Rep; 2016 Feb; 2016():. PubMed ID: 26903363
[TBL] [Abstract][Full Text] [Related]
60. Primary cutaneous large B cell lymphoma masquerading as lupus vulgaris.
Gupta P; Shruti S; Siraj F; Bhargava A; Khullar G
J Cancer Res Ther; 2023; 19(5):1477-1479. PubMed ID: 37787336
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
